Xiaobu Ye

10.8k total citations · 3 hit papers
151 papers, 6.8k citations indexed

About

Xiaobu Ye is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaobu Ye has authored 151 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Genetics, 53 papers in Oncology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaobu Ye's work include Glioma Diagnosis and Treatment (76 papers), Brain Metastases and Treatment (29 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Xiaobu Ye is often cited by papers focused on Glioma Diagnosis and Treatment (76 papers), Brain Metastases and Treatment (29 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Xiaobu Ye collaborates with scholars based in United States, Germany and Spain. Xiaobu Ye's co-authors include Stuart A. Grossman, Serena Desideri, Steven Piantadosi, Jian Campian, Joy Fisher, Michael Lim, Myrna R. Rosenfeld, Jaishri O. Blakeley, Glenn J. Lesser and Burt Nabors and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xiaobu Ye

140 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide

2011 413 citations Stuart A. Grossman, Xiaobu Ye et al. Clinical Cancer Research profile →
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

2014 409 citations Myrna R. Rosenfeld, Xiaobu Ye et al. profile →
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma

2013 371 citations Kaisorn L. Chaichana, Xiaobu Ye et al. Neuro-Oncology profile →

Peers

Countries citing papers authored by Xiaobu Ye

Since Specialization

Citations

This map shows the geographic impact of Xiaobu Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobu Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobu Ye more than expected).

Fields of papers citing papers by Xiaobu Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobu Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobu Ye. The network helps show where Xiaobu Ye may publish in the future.

Co-authorship network of co-authors of Xiaobu Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobu Ye. A scholar is included among the top collaborators of Xiaobu Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobu Ye. Xiaobu Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma 2024 ·Clinical Cancer Research ·Karisa C. Schreck, Roy E. Strowd, Burt Nabors, Benjamin M. Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth Aldape, (unknown), Serena Desideri, Joy Fisher, (unknown), (unknown), Michelle A. Rudek, Chetan Bettegowda, Stuart A. Grossman, Xiaobu Ye	7
2	EPID-29. EPIDEMIOLOGICAL CHARACTERIZATION OF BRAIN METASTASES IN MELANOMA: A LARGE POPULATION BASED-STUDY FROM 2014-2024 2024 ·Neuro-Oncology ·(unknown), (unknown), (unknown), Kelly Jiang, (unknown), (unknown), David Kamson, Kristin J. Redmond, Govind Warrier, Evan J. Lipson, Xiaobu Ye, (unknown), Jordina Rincón-Torroella	1
3	Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma 2024 ·Neuro-Oncology Advances ·Samuel Ryu, Xiaobu Ye, Jeffrey J. Olson, Tom Mikkelsen, Lev Bangiyev, Glenn J. Lesser, Tracy T. Batchelor, Burt Nabors, Serena Desideri, Tobias Walbert, Stuart A. Grossman	4
4	Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma 2023 ·Journal of Neuro-Oncology ·Roy E. Strowd, Benjamin M. Ellingson, Catalina Raymond, Jingwen Yao, Patrick Y. Wen, Manmeet S. Ahluwalia, Anna F. Piotrowski, Arati Desai, Jennifer Clarke, Frank S. Lieberman, Serena Desideri, Burt Nabors, Xiaobu Ye, Stuart A. Grossman	17
5	Impact of Antithrombotic Medications and Reversal Strategies on the Surgical Management and Outcomes of Traumatic Acute Subdural Hematoma 2023 ·World Neurosurgery ·(unknown), Kathleen R. Ran, (unknown), (unknown), (unknown), Jordina Rincón-Torroella, Xiaobu Ye, James P. Byrne, José I. Suárez, (unknown), Christopher M. Jackson, (unknown), Gary L. Gallia, Judy Huang, Jon Weingart, Tej D. Azad, Chetan Bettegowda	3
6	An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission 2021 ·Clinical Cancer Research ·(unknown), Carol Ann Huff, Anna Ferguson, (unknown), (unknown), Lakshmi Rudraraju, (unknown), Syed Abbas Ali, Philip Imus, Christian B. Gocke, Rachel Gittelman, Sarah Johnson, Catherine Sanders, Marissa Vignali, Anita K. Gandhi, Xiaobu Ye, Kimberly Noonan, Ivan Borrello	12
7	White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab 2019 ·Journal of Neuro-Oncology ·(unknown), Xiaobu Ye, Omar Dzaye, Nina D. Wagner‐Johnston, Lode J. Swinnen, Douglas E. Gladstone, (unknown), David Kamson, (unknown), Stuart A. Grossman, Doris Lin, Matthias Holdhoff	11
8	A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Kristin J. Redmond, Daniel M. Sciubba, Majid Khan, Chengcheng Gui, Sheng-Fu Larry Lo, Ziya L. Gokaslan, (unknown), Lawrence Kleinberg, Jimm Grimm, Xiaobu Ye, Michael Lim	51
9	Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma 2018 ·Clinical Cancer Research ·Jaishri O. Blakeley, Stuart A. Grossman, S. Andrew, Tom Mikkelsen, Myrna R. Rosenfeld, Manmeet S. Ahluwalia, Burt Nabors, April F. Eichler, (unknown), Serena Desideri, Xiaobu Ye	18
10	The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma 2018 ·Fluids and Barriers of the CNS ·Sadhana Jackson, Jon Weingart, Edjah K. Nduom, (unknown), Richard T. De George, Dorothea McAreavey, Xiaobu Ye, Nicole M. Anders, Cody J. Peer, William D. Figg, Mark R. Gilbert, Michelle A. Rudek, Stuart A. Grossman	52
11	The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma 2017 ·Journal of Neuro-Oncology ·Iddo Paldor, Sara Abbadi, N.-X. Bonne, Xiaobu Ye, Fausto J. Rodríguez, (unknown), (unknown), (unknown), Marco Giovannini, Henry Brem, Jaishri O. Blakeley, Betty Tyler	9
12	Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization 2016 ·Clinical Cancer Research ·Matthias Holdhoff, Güneş Güner, Fausto J. Rodríguez, Jessica Hicks, Qizhi Zheng, Michael Forman, Xiaobu Ye, Stuart A. Grossman, Alan K. Meeker, Christopher M. Heaphy, Charles G. Eberhart, Angelo M. De Marzo, Ravit Arav‐Boger	52
13	Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas 2016 ·Journal of Clinical Oncology ·Jaishri O. Blakeley, Xiaobu Ye, Dan G. Duda, Chris Halpin, Amanda L. Bergner, Alona Muzikansky, Vanessa L. Merker, Elizabeth R. Gerstner, Laura M. Fayad, Shivani Ahlawat, Michael A. Jacobs, Rakesh K. Jain, Christopher Zalewski, Eva Dombi, Brigitte C. Widemann, Scott R. Plotkin	86
14	Patterns of Radiation-Associated Lymphopenia in Children with Cancer 2016 ·Cancer Investigation ·Miloš D. Miljković, Stuart A. Grossman, Xiaobu Ye, Susannah G. Ellsworth, Stephanie A. Terezakis	6
15	MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel 2015 ·Journal of Clinical Neuroscience ·Rachel Grossman, Peter C. Burger, Ethan Soudry, Betty Tyler, Kaisorn L. Chaichana, Jon Weingart, Alessandro Olivi, Gary L. Gallia, David Sidransky, Alfredo Quiñones‐Hinojosa, Xiaobu Ye, Henry Brem	21
16	Glioblastoma recurrence patterns near neural stem cell regions 2015 ·Radiotherapy and Oncology ·Linda Chen, Kaisorn L. Chaichana, Lawrence Kleinberg, Xiaobu Ye, Alfredo Quiñones‐Hinojosa, Kristin J. Redmond	60
17	Baclofen dosage after traumatic spinal cord injury: A multi-decade retrospective analysis 2014 ·Clinical Neurology and Neurosurgery ·Ashan Veerakumar, Jennifer J. Cheng, Abraham Sunshine, Xiaobu Ye, Richard D. Zorowitz, William S. Anderson	4
18	Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study 2013 ·Human Pathology ·Ashley Cimino‐Mathews, Xiaobu Ye, Alan K. Meeker, Pedram Argani, Leisha A. Emens	101
19	Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial 2009 ·Journal of Clinical Oncology ·Stuart A. Grossman, Xiaobu Ye, Marc C. Chamberlain, Tom Mikkelsen, Tracy T. Batchelor, Serena Desideri, Steven Piantadosi, Joy Fisher, Howard A. Fine	131
20	Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation 2009 ·Journal of Clinical Oncology ·Leisha A. Emens, Justin M. Asquith, James M. Leatherman, Barry Kobrin, (unknown), (unknown), (unknown), Maithili M. Daphtary, Barbara Biedrzycki, Antonio C. Wolff, Vered Stearns, Mary L. Disis, Xiaobu Ye, Steven Piantadosi, John H. Fetting, Nancy E. Davidson, Elizabeth M. Jaffee	178

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact